Santen Phamaceutical Co., Ltd. Company Profile

18:19 EDT 17th March 2018 | BioPortfolio

Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and development to production and sales of prescription and over-the-counter pharmaceuticals.Today, Santen specializes in original ophthalmic and anti-rheumatic pharmaceuticals as it works to create superior pharmaceuticals for all types of ophthalmic disorders and offer information that meets clinical needs. As a result, Santen leads Japan's market for prescription ophthalmics, which represent over 80 percent of Company sales.
With marketing and development bases in Japan, the United States and Europe, backed by first-rate R&D capabilities, Santen aims to increase corporate value to become a world-class company that delivers unique products to patients worldwide.


9-19 Shimoshinjo 3-chome


Phone: 81-6-6321-7000
Fax: 81-6-6321-8400

News Articles [34 Associated News Articles listed on BioPortfolio]

Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)

EMERYVILLE, Calif., Dec. 21, 2017 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (Osaka, Japan) and Santen Inc. (Emeryville, CA, USA) today announced that the U.S. Food and Drug Administration (FDA) ...

NTC and Santen partner on fixed combination ophthalmic therapeutic solution

Italian pharmaceutical company, NTC, has entered into a commercial partnership with Santen Pharmaceutical — a pharma company focused on ophthalmology.

BRIEF—Mundipharma and Santen expand partnership in ophthalmology

UK-based Mundipharma has boosted its partnership with Japanese ophthalmic specialist Santen Pharmaceutical.

BRIEF—Executive reshuffle at Santen Pharmaceutical

Japan’s Santen Pharmaceutical has reshuffled its executive team, appointing current senior corporate…

Mundipharma expands Santen partnership

Mundipharma has expanded a partnership with Santen Pharmaceutical, according to a press release.The extension of an existing license for Saflutan (tafluprost) will add approximately 50 Middle Eastern ...

VIDEO: Santen reaffirms commitment to glaucoma treatment

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Ram Palanki, PharmD, senior vice president of the Americas commercial for Santen, discusses the company’s pipeline in glaucoma therapy and ...

Luis Iglesias replaces Shigeo Taniuchi as head of Santen EMEA

The new head of Santen Europe, Middle East and Africa (EMEA) is Luis Iglesias, the Japanese ophthalmology…

Asia Executives To Watch: Senior Changes At Santen, GSK Consumer Health, Others

A new month brings new appointments in the Asia-Pacific region, including a new president with a past assignment in China...    

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Alamast [Vistakon Pharmaceuticals LLC]

ALAMAST (pemirolast potassium ophthalmic solution) 0.1%

Phentermine hydrochloride [Apotheca, Inc.]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [13 Associated Companies listed on BioPortfolio]

Santen Phamaceutical Co., Ltd.

Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and...

Santen GmbH.

As a specialty company dedicated to the ophthalmic and anti-rheumatic fields, Santen carries out the research, development, sales, and marketing of pharmaceuticals. The company ha...

Santen Inc.

Santen Inc., based in Emeryville, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. ...

Santen Incorporated

Santen Inc. is responsible for the development and commercialization of eye care pharmaceuticals in the U.S. It also serves as the international headquarters for Santen's business in Europe, with resp...

Santen Pharmaceutical Co., Ltd.

More Information about "Santen Phamaceutical Co., Ltd." on BioPortfolio

We have published hundreds of Santen Phamaceutical Co., Ltd. news stories on BioPortfolio along with dozens of Santen Phamaceutical Co., Ltd. Clinical Trials and PubMed Articles about Santen Phamaceutical Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Santen Phamaceutical Co., Ltd. Companies in our database. You can also find out about relevant Santen Phamaceutical Co., Ltd. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record